The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group.
Saved in:
| Title: | The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group. |
|---|---|
| Authors: | El Bairi K; Department of Medical Oncology, Mohammed VI University Hospital, Faculty of Medicine and Pharmacy, Mohammed Ist University, Oujda, Morocco. k.elbairi@ump.ac.ma., Haynes HR; Department of Cellular Pathology, Great Western Hospital, Swindon, UK.; Translational Health Sciences, University of Bristol, Bristol, UK., Blackley E; Division of Research, Peter MacCallum Cancer Centre, Melbourne, Australia., Fineberg S; Department of Pathology, Montefiore Medical Center and the Albert Einstein College of Medicine, Bronx, NY, USA., Shear J; Chief Information Officer, WISS & Company, LLP and President J. Shear Consulting, LLC-Ardsley, Ardsley, NY, USA., Turner S; ICPV, Independent Cancer Patient Voice, London, UK., de Freitas JR; Department of Pathology and Legal Medicine, Medical School of the Federal University of Bahia, Salvador, Brazil., Sur D; Department of Medical Oncology, University of Medicine 'I. Hatieganu', Cluj Napoca, Romania., Amendola LC; Brazilian Society of Oncology, Salvador, Brazil., Gharib M; Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran., Kallala A; Hopital Charles Nicolle, Tunis, Tunisia., Arun I; Department of Histopathology, Tata Medical Center, Kolkata, India., Azmoudeh-Ardalan F; Department of Pathology, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran., Fujimoto L; Pathology and Legal Medicine, Amazon Federal University, Belém, Brazil., Sua LF; Department of Pathology and Laboratory Medicine, Fundacion Valle del Lili, and Faculty of Health Sciences, Universidad ICESI, Cali, Colombia., Liu SW; Sichuan Cancer Hospital, Chengdu, China., Lien HC; Department of Pathology, National Taiwan University Hospital, Taipei, Taiwan., Kirtani P; Department of Histopathology, Manipal Hospitals Dwarka, New Delhi, India., Balancin M; Department of Pathology, Faculty of Medicine, University of São Paulo, São Paulo, Brazil., El Attar H; Apc labs - Annasr Pathology Center, El Jadida, Morocco., Guleria P; Army Hospital Research and Referral, Delhi Cantt, New Delhi, India., Yang W; Aginome Scientific Pte Ltd, Xiamen, China., Shash E; Breast Cancer Comprehensive Center, National Cancer Institute, Cairo University, Cairo, Egypt., Chen IC; Department of Oncology, National Taiwan University Cancer Center, Taipei, Taiwan.; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan., Bautista V; Department of Pathology, Breast Cancer Center FUCAM, Mexico City, Mexico., Do Prado Moura JF; Centro de Pesquisas Clinicas do IMIP, Recife, Brazil., Rapoport BL; The Medical Oncology Centre of Rosebank, Johannesburg, South Africa.; Department of Immunology, Faculty of Health Sciences, University of Pretoria, corner Doctor Savage Road and Bophelo Road, Pretoria, 0002, South Africa., Castaneda C; Department of Medical Oncology, Instituto Nacional de Enfermedades Neoplásicas, Lima, 15038, Peru.; Faculty of Health Sciences, Universidad Cientifica del Sur, Lima, Peru., Spengler E; Departmento de Patologia, Hospital Universitario Austral, Pilar, Argentina., Acosta-Haab G; Department of Pathology, Hospital de Oncología Maria Curie, Buenos Aires, Argentina., Frahm I; Department of Pathology, Sanatorio Mater Dei, Buenos Aires, Argentina., Sanchez J; Department of Research, Instituto Nacional de Enfermedades Neoplasicas, Lima, 15038, Peru., Castillo M; Department of Research, Instituto Nacional de Enfermedades Neoplasicas, Lima, 15038, Peru., Bouchmaa N; Institute of Biological Sciences, Mohammed VI Polytechnic University (UM6P), 43 150, Ben-Guerir, Morocco., Md Zin RR; Department of Pathology, Faculty of Medicine, UKM Medical Centre, Kuala Lumpur, Malaysia., Shui R; Department of Pathology, Fudan University Cancer Center, Shanghai, China., Onyuma T; Kenyatta National Hospital, Nairobi, Kenya., Yang W; Department of Pathology, Fudan University Cancer Center, Shanghai, China., Husain Z; Praava Health, Dhaka, Bangladesh., Willard-Gallo K; Molecular Immunology Unit, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium., Coosemans A; Laboratory of Tumour Immunology and Immunotherapy, Department of Oncology, KU Leuven, Leuven, Belgium., Perez EA; Department of Hematology/Oncology, Mayo Clinic, Jacksonville, FL, USA., Provenzano E; Department of Histopathology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Ericsson PG; Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA., Richardet E; Clinical Oncology Unit, Instituto Oncológico Córdoba, Córdoba, Argentina., Mehrotra R; India Cancer Research Consortium-ICMR, Department of Health Research, New Delhi, India., Sarancone S; Department of Pathology, Laboratorio QUANTUM, Rosario, Argentina., Ehinger A; Department of Clinical Genetics and Pathology, Skåne University Hospital, Lund University, Lund, Sweden., Rimm DL; Department of Pathology, Yale School of Medicine, New Haven, CT, USA., Bartlett JMS; Diagnostic Development, Ontario Institute for Cancer Research, Toronto, Canada.; Cancer Research UK Edinburgh Centre, Institute of Genetics and Cancer, The University of Edinburgh, Edinburgh, UK.; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada., Viale G; Department of Pathology, Istituto Europeo di Oncologia IRCCS, and University of Milan, Milan, Italy., Denkert C; Institute of Pathology, Universitätsklinikum Gießen und Marburg GmbH, Standort Marburg and Philipps-Universität Marburg, Marburg, Germany., Hida AI; Department of Pathology, Matsuyama Shimin Hospital, Matsuyama, Japan., Sotiriou C; Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium., Loibl S; German Breast Group, Neu-Isenburg, Germany., Hewitt SM; Laboratory of Pathology, National Cancer Institute, NIH, Bethesda, MD, USA., Badve S; Department of Pathology and Laboratory Medicine, Indiana University, Indianapolis, USA., Symmans WF; Department of Pathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA., Kim RS; National Surgical Adjuvant Breast and Bowel Project (NSABP)/NRG Oncology, Pittsburgh, PA, USA., Pruneri G; Department of Pathology, RCCS Fondazione Istituto Nazionale Tumori and University of Milan, School of Medicine, Milan, Italy., Goel S; Division of Research, Peter MacCallum Cancer Centre, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, Australia., Francis PA; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, Australia.; Medical Oncology Department, Peter MacCallum Cancer Centre, Melbourne, Australia., Inurrigarro G; Department of pathology Sanatorio Mater Dei, Buenos Aires, Argentina., Yamaguchi R; Department of Pathology and Laboratory Medicine, Kurume University Medical Center, Kurume, Fukuoka, Japan., Garcia-Rivello H; Servicio de Anatomía Patológica, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina., Horlings H; Division of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Afqir S; Department of Medical Oncology, Mohammed VI University Hospital, Faculty of Medicine and Pharmacy, Mohammed Ist University, Oujda, Morocco., Salgado R; Division of Research, Peter MacCallum Cancer Centre, Melbourne, Australia.; Department of Pathology, GZA-ZNA Hospitals, Antwerp, Belgium., Adams S; Perlmutter Cancer Center, New York University Medical School, New York, NY, USA., Kok M; Divisions of Medical Oncology, Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Dieci MV; Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy.; Medical Oncology 2, Istituto Oncologico Veneto IOV-IRCCS, Padova, Italy., Michiels S; Service de Biostatistique et d'Epidémiologie, Gustave Roussy, Oncostat U1018, Inserm, University Paris-Saclay, labeled Ligue Contre le Cancer, Villejuif, France., Demaria S; Department of Radiation Oncology, Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA., Loi S; Division of Research, Peter MacCallum Cancer Centre, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, Australia. |
| Corporate Authors: | International Immuno-Oncology Biomarker Working Group |
| Source: | NPJ breast cancer [NPJ Breast Cancer] 2021 Dec 01; Vol. 7 (1), pp. 150. Date of Electronic Publication: 2021 Dec 01. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Breast Cancer Research Foundation Country of Publication: United States NLM ID: 101674891 Publication Model: Electronic Cited Medium: Print ISSN: 2374-4677 (Print) Linking ISSN: 23744677 NLM ISO Abbreviation: NPJ Breast Cancer Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2374-4677 |
|---|---|
| DOI: | 10.1038/s41523-021-00346-1 |
